Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

ctDNA monitoring in hepatocellular carcinoma and metastatic colorectal cancer

Interventional study of serial ctDNA in hepatocellular carcinoma and in colorectal cancer metastatic to the liver. The registry lists the phase as not applicable and the primary outcome as assessment of the clinical value of the ctDNA level. ClinicalTrials.gov lists the study as recruiting.

Medical University of Warsaw